What are the different phases of drug development?

What are the different phases of drug development?

• A. preclinical; Phase 1; Phase 2; Phase 3; Submission of NDA; Phase 4.
• B. Phase 1; preclinical; Phase 2; Phase 3; NDA submission; Phase 4.
• C. Phase 3; Phase 2; Phase 1; Phase 4; Preclinical; NDA submission.
• D. Phase 1; Phase 2; Phase 3; Phase 4; Preclinical; NDA submission.

Answer: (A)

Drug development follows a clear progression from safety and biology testing to human trials, then regulatory submission, and finally post-marketing monitoring. First, preclinical studies assess safety and mechanism in the lab and in animals. If those look favorable, we move to humans with Phase 1 trials to test safety and pharmacokinetics in a small group. Phase 2 then assesses preliminary effectiveness and continues safety evaluation in a larger group. Phase 3 involves large-scale trials to confirm efficacy and monitor adverse effects. After compiling favorable data, the developer submits a New Drug Application (NDA) to regulators for approval. Once approved, Phase 4 continues to monitor long-term safety in the general population. This exact sequence—preclinical, Phase 1, Phase 2, Phase 3, NDA submission, Phase 4—is why the option listing that order is correct. Other options misplace stages or duplicate/precede stages in the wrong order.

Drug development follows a clear progression from safety and biology testing to human trials, then regulatory submission, and finally post-marketing monitoring. First, preclinical studies assess safety and mechanism in the lab and in animals. If those look favorable, we move to humans with Phase 1 trials to test safety and pharmacokinetics in a small group. Phase 2 then assesses preliminary effectiveness and continues safety evaluation in a larger group. Phase 3 involves large-scale trials to confirm efficacy and monitor adverse effects. After compiling favorable data, the developer submits a New Drug Application (NDA) to regulators for approval. Once approved, Phase 4 continues to monitor long-term safety in the general population. This exact sequence—preclinical, Phase 1, Phase 2, Phase 3, NDA submission, Phase 4—is why the option listing that order is correct. Other options misplace stages or duplicate/precede stages in the wrong order.